Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer

Published:2020-09-17 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Su Chaoyue,Wang Hui,Liu Yunru,Guo Qiaoru,Zhang Lingling,Li Jiajun,Zhou Wenmin,Yan Yanyan,Zhou Xinke,Zhang Jianye

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference113 articles.

1. Cancer screening in the United States, 2018:A review of current American Cancer Society guidelines and current issues in cancer screening;Smith;CA Cancer J Clin.,2018

2. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy;Osmani;Semin Cancer Biol.,2018

3. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1;Huang;Signal Transduct Target Ther.,2020

4. Anti-PD-1/PD-L1 therapy for non-small-cell lung cancer: toward personalized medicine and combination strategies;Sui;J Immunol Res.,2018

5. PD-L1 in the palm of your hand: palmitoylation as a target for immuno-oncology;von Knethen;Signal Transduct Target Ther.,2019

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing cancer immunotherapy: Exploring strategies to target the PD-1/PD-L1 axis and analyzing the associated patent, regulatory, and clinical trial landscape;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

2. The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT;Onco;2024-07-01

3. Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses;Nature Communications;2024-06-03

4. Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway;Oncogenesis;2024-05-25

5. Association between immune-related adverse events and prognosis in patients with advanced non-small cell lung cancer: a systematic review and meta-analysis;Frontiers in Oncology;2024-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3